A detailed history of Parallel Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 6,991 shares of RXST stock, worth $241,539. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,991
Previous 7,933 11.87%
Holding current value
$241,539
Previous $477,000 27.67%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$40.78 - $57.04 $38,414 - $53,731
-942 Reduced 11.87%
6,991 $345,000
Q2 2024

Aug 08, 2024

BUY
$50.42 - $64.29 $399,981 - $510,012
7,933 New
7,933 $477,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $955M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.